See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Applied Materials, Inc. (AMAT) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Applied Materials, Inc. (AMAT) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for November 21st
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 21st:
Applied Materials, Inc. (AMAT - Free Report) : This provider of manufacturing equipment, services and software has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.9% over the last 60 days.
Applied Materials, Inc. Price and Consensus
Applied Materials, Inc. price-consensus-chart | Applied Materials, Inc. Quote
Applied Materials’ shares gained 13.3% over the last one month, which is more than S&P 500’s gain of 3.4%. The company possesses a Momentum Score of A.
Applied Materials, Inc. Price
Applied Materials, Inc. price | Applied Materials, Inc. Quote
Ascendis Pharma A/S (ASND - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.6% over the last 60 days.
Ascendis Pharma A/S Price and Consensus
Ascendis Pharma A/S price-consensus-chart | Ascendis Pharma A/S Quote
Ascendis Pharma’s shares gained 13.8% over the last one month. The company possesses a Momentum Score of A.
Ascendis Pharma A/S Price
Ascendis Pharma A/S price | Ascendis Pharma A/S Quote
Apyx Medical Corporation (APYX - Free Report) : This medical technology company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.1% over the last 60 days.
Bovie Medical Corporation Price and Consensus
Bovie Medical Corporation price-consensus-chart | Bovie Medical Corporation Quote
Apyx Medical’s shares gained 4.6% over the last one month. The company possesses a Momentum Score of A.
Bovie Medical Corporation Price
Bovie Medical Corporation price | Bovie Medical Corporation Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.5% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>